400 related articles for article (PubMed ID: 36680071)
1. Determinants of Retroviral Integration and Implications for Gene Therapeutic MLV-Based Vectors and for a Cure for HIV-1 Infection.
Pellaers E; Bhat A; Christ F; Debyser Z
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680071
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor binding sites are genetic determinants of retroviral integration in the human genome.
Felice B; Cattoglio C; Cittaro D; Testa A; Miccio A; Ferrari G; Luzi L; Recchia A; Mavilio F
PLoS One; 2009; 4(2):e4571. PubMed ID: 19238208
[TBL] [Abstract][Full Text] [Related]
3. Integration site selection by retroviral vectors: molecular mechanism and clinical consequences.
Daniel R; Smith JA
Hum Gene Ther; 2008 Jun; 19(6):557-68. PubMed ID: 18533894
[TBL] [Abstract][Full Text] [Related]
4. Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses.
Derse D; Crise B; Li Y; Princler G; Lum N; Stewart C; McGrath CF; Hughes SH; Munroe DJ; Wu X
J Virol; 2007 Jun; 81(12):6731-41. PubMed ID: 17409138
[TBL] [Abstract][Full Text] [Related]
5. Retroviral DNA integration: viral and cellular determinants of target-site selection.
Lewinski MK; Yamashita M; Emerman M; Ciuffi A; Marshall H; Crawford G; Collins F; Shinn P; Leipzig J; Hannenhalli S; Berry CC; Ecker JR; Bushman FD
PLoS Pathog; 2006 Jun; 2(6):e60. PubMed ID: 16789841
[TBL] [Abstract][Full Text] [Related]
6. Retroviral infection of hES cells produces random-like integration patterns.
Lim KI
Mol Cells; 2012 May; 33(5):525-31. PubMed ID: 22526396
[TBL] [Abstract][Full Text] [Related]
7. Disclosing the Parameters Leading to High Productivity of Retroviral Producer Cells Lines: Evaluating Random Versus Targeted Integration.
Bandeira VS; Tomás HA; Alici E; Carrondo MJ; Coroadinha AS
Hum Gene Ther Methods; 2017 Apr; 28(2):78-90. PubMed ID: 28301970
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms governing lentivirus integration site selection.
Ciuffi A
Curr Gene Ther; 2008 Dec; 8(6):419-29. PubMed ID: 19075625
[TBL] [Abstract][Full Text] [Related]
9. Proviruses with Long-Term Stable Expression Accumulate in Transcriptionally Active Chromatin Close to the Gene Regulatory Elements: Comparison of ASLV-, HIV- and MLV-Derived Vectors.
Miklík D; Šenigl F; Hejnar J
Viruses; 2018 Mar; 10(3):. PubMed ID: 29517993
[TBL] [Abstract][Full Text] [Related]
10. Integration target site selection for retroviruses and transposable elements.
Wu X; Burgess SM
Cell Mol Life Sci; 2004 Oct; 61(19-20):2588-96. PubMed ID: 15526164
[TBL] [Abstract][Full Text] [Related]
11. Retroviral vectors for gene therapy of AIDS and cancer.
Chang LJ; He J
Curr Opin Mol Ther; 2001 Oct; 3(5):468-75. PubMed ID: 11699891
[TBL] [Abstract][Full Text] [Related]
12. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences.
Mitchell RS; Beitzel BF; Schroder AR; Shinn P; Chen H; Berry CC; Ecker JR; Bushman FD
PLoS Biol; 2004 Aug; 2(8):E234. PubMed ID: 15314653
[TBL] [Abstract][Full Text] [Related]
13. Retroviral integration: Site matters: Mechanisms and consequences of retroviral integration site selection.
Demeulemeester J; De Rijck J; Gijsbers R; Debyser Z
Bioessays; 2015 Nov; 37(11):1202-14. PubMed ID: 26293289
[TBL] [Abstract][Full Text] [Related]
14. Host factors for retroviral integration site selection.
Debyser Z; Christ F; De Rijck J; Gijsbers R
Trends Biochem Sci; 2015 Feb; 40(2):108-16. PubMed ID: 25555456
[TBL] [Abstract][Full Text] [Related]
15. Alteration of gammaretroviral vector integration patterns by insertion of histone and leucine zipper into integrase.
Yang Y; Lee JE; Jeong HY; Shim JY; Baek MJ; Son MJ; Kim YJ; Noh H; Lim KI
Biotechnol Bioeng; 2020 Dec; 117(12):3924-3937. PubMed ID: 32816306
[TBL] [Abstract][Full Text] [Related]
16. Modification of integration site preferences of an HIV-1-based vector by expression of a novel synthetic protein.
Silvers RM; Smith JA; Schowalter M; Litwin S; Liang Z; Geary K; Daniel R
Hum Gene Ther; 2010 Mar; 21(3):337-49. PubMed ID: 19877879
[TBL] [Abstract][Full Text] [Related]
17. Integration site selection by retroviruses.
Cereseto A; Giacca M
AIDS Rev; 2004; 6(1):13-21. PubMed ID: 15168737
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of retroviral integration site selection.
Kvaratskhelia M; Sharma A; Larue RC; Serrao E; Engelman A
Nucleic Acids Res; 2014; 42(16):10209-25. PubMed ID: 25147212
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral vectors and gene therapy.
Klimatcheva E; Rosenblatt JD; Planelles V
Front Biosci; 1999 Jun; 4():D481-96. PubMed ID: 10352135
[TBL] [Abstract][Full Text] [Related]
20. Integration site selection by lentiviruses: biology and possible control.
Bushman FD
Curr Top Microbiol Immunol; 2002; 261():165-77. PubMed ID: 11892246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
